Chemotherapy of lung cancer: A global perspective of the role of ifosfamide - Wikidata - awgldk - TriplyDB

Chemotherapy of lung cancer: A global perspective of the role of ifosfamide

Chemotherapy of lung cancer: A global perspective of the role of ifosfamide

http://www.wikidata.org/entity/Q35200383

about

The efficacy of the inhalation of an aerosolized Group A streptococcal preparation in the treatment of lung cancer.

P2860

Q42911493-DBF0A589-8C88-4AC4-AEF9-57BB19650749

P2860

Chemotherapy of lung cancer: A global perspective of the role of ifosfamide

http://www.wikidata.org/entity/Q35200383

description

2012 nî lūn-bûn

@nan

2012 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մարտին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Chemotherapy of lung cancer: A global perspective of the role of ifosfamide

@ast

Chemotherapy of lung cancer: A global perspective of the role of ifosfamide

@en

type

label

Chemotherapy of lung cancer: A global perspective of the role of ifosfamide

@ast

Chemotherapy of lung cancer: A global perspective of the role of ifosfamide

@en

prefLabel

Chemotherapy of lung cancer: A global perspective of the role of ifosfamide

@ast

Chemotherapy of lung cancer: A global perspective of the role of ifosfamide

@en

P1433

Q35200383-0B247853-C859-4EB1-9ABE-EC35B9A8EC2B

P1476

Q35200383-51608426-4F0E-45B4-ACF8-F7E95C465C7B

P2093

Q35200383-9AEE0EB6-9F74-4DF7-AFC5-855DBDD4F8EE

Q35200383-C88EE616-C192-4C36-BFC3-27F27E640E46

P2860

Q35200383-0C4E3414-DBEF-4553-9AEB-C1EFEB416F4D

Q35200383-13AF1004-1C84-4772-97AD-F8629A47FFED

Q35200383-14828E88-6899-42BA-BAB5-5E57C831AC1D

Q35200383-157BD775-3ABB-4114-921D-21751C3642DD

Q35200383-19D10CDA-DCB3-43B8-B95B-E3B6BB57008C

Q35200383-1C7D4974-FD56-44A2-A04C-07275F792A4A

Q35200383-2B6F1C3E-A1BC-42A0-B0DF-0D9D1502560F

Q35200383-2CAC320E-5660-4654-A9F5-93E094143635

Q35200383-2DABC7FB-2F1C-4A4E-969E-7FB9CA84BBF8

Q35200383-34124B06-C7C2-4D0D-A688-3D5695362D8A

P304

Q35200383-19A816D3-E458-43CB-8C8B-9A8AE50EF8C1

P31

Q35200383-33B12997-0406-477E-9A93-97C3B8C4B2E0

P356

Q35200383-F3F25489-C524-45DE-A9D9-7CC7C14533DF

P433

Q35200383-FFC4108D-0033-4380-A790-E75BBEDFD78B

P478

Q35200383-84E39976-A6B7-4115-8EE8-00DEA3DD0342

P577

Q35200383-C7644ECC-EC4D-4386-A706-211A1C948ED2

P698

Q35200383-A1E9D7AD-FB39-4A47-8218-4722D440755F

P921

Q35200383-D05CDE4F-17D8-470E-A9AC-3379EA4FBF2F

P932

Q35200383-572F5003-8300-4599-A171-06A0A98686D2

P356

J.ISSN.2218-6751.2011.12.02

P1433

Translational lung cancer research

P1476

Chemotherapy of lung cancer: A global perspective of the role of ifosfamide

@en

P2093

Caicun Zhou

http://www.w3.org/2001/XMLSchema#string

Christian Manegold

http://www.w3.org/2001/XMLSchema#string

P2860

Gemcitabine, Ifosfamide and Navelbine (GIN): activity and safety of a non-platinum-based triplet in advanced non-small-cell lung cancer (NSCLC)

Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial

Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.

Phase II study of paclitaxel, ifosfamide, and cisplatin as second-line treatment in relapsed small-cell lung cancer.

Combination chemotherapy in patients with malignant pleural effusions from non-small cell lung cancer : cisplatin, ifosfamide, and irinotecan with recombinant human granulocyte colony-stimulating factor support.

Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project.

Combination of cisplatin, ifosfamide, and irinotecan with rhG-CSF support for the treatment of refractory or relapsed small-cell lung cancer.

Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer.

Phase II study of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with stage IIIb and IV non-small-cell lung cancer

Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer Group.

P304

61-71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3978/J.ISSN.2218-6751.2011.12.02

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25806156

http://www.w3.org/2001/XMLSchema#string

P921

P932

4367585

http://www.w3.org/2001/XMLSchema#string